Asgard Therapeutics’ Financing Round

Roschier represented RV Invest and Johnson & Johnson Innovation on the deal. Asgard Therapeutics AB, a Swedish biotech company pioneering in vivo direct cell reprogramming for...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Vitruvian’s Acquisition of Aspia

Kirkland & Ellis is advising Vitruvian Partners in the transaction, while Roschier and MCF are representing IK Partners. Vitruvian Partners announced it has agreed to acquire Aspia...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here